Groningen

• Evaluation of [18F]MC225 to measure P-glycoprotein function in neurodegenerative disease Pending
  2024-518865-85-00 4 Alzheimers Disease
• GRoningen Early-PD Ambroxol Treatment Pharmacokinetics Pending
  2024-519088-16-01 3 Parkinson's disease
• A PHASE 1 STUDY WITH SINGLE ASCENDING DOSE, MULTIPLE ASCENDING DOSE AND FOOD EFFECT OF LMT503 IN HEALTHY SUBJECTS. Pending
  2024-519180-17-00 1 Healthy volonteers
• A study investigating the safety, absorption, and elimination of RO7795068, a new compound that may potentially be used in the treatment of … Pending
  2024-519296-25-00 3 Healthy volunteers
• A Phase Ib/II Open-Label, Multicentre Platform Study Evaluating Novel Combinations in Participants with Advanced or Metastatic Non-Small Cel … Pending
  2024-519786-22-01 9 metastatic non-small cell lung cancer (NSCLC)
• A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease Pending
  2025-521113-13-00 10 Early Parkinson’s Disease
• Phase 3 trial of VMX-C001 vs usual pharmacological care in patients taking a FXa direct oral anticoagulant who require urgent surgery with o … Pending
  2025-521632-12-00 5 Patients on Factor Xa inhibitor treatment needing an urgent interventi
• A Study to Determine the Effectiveness of a Test Drug ([68Ga]BED003) for the Detection of Pancreatic, Colorectal, Gastric, Breast and Ovaria … Pending
  2025-521983-36-00 4 Colorectal cancer (CRC), gastric cancer (GC), pancreatic ductal adenoc
• Fluorescence Intraoperative Surgical Margin Analysis in Head and Neck Cancer: Clinical Validation Pending
  2025-522027-95-00 5 oral squamous cell carcinoma
• REVITALISE Study Pending
  2025-522060-32-00 4 STEMI (ST elevated Myocardial Infarction)
• A single arm phase II study evaluating intracranial efficacy of tarlatamab in patients with asymptomatic active brain metastases from small … Pending
  2025-522162-75-00 4 patients with asymptomatic active brain metastases from small cell lun
• HOVON 178 WM: Treatment of Waldenstrom’s macroglobulinemia with epcoritamab if the disease comes back during or after previous treatment Pending
  2025-522295-91-00 9 relapsed or refractory Waldenstrom’s macroglobulinemia
• CANagliflozin In DIAlysis Patients Pending
  2025-522742-46-00 6 Chronic Kidney disease
• Phase 3 Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Platinum Resistant Ovarian Cancer With Cyclin E1 Overexpression Pending
  2025-522748-42-00 5 Ovarian cancer
• PROTECx - Pembrolizumab Registry for Outcomes and Treatment Evaluation in Cervical Cancer Pending
  2025-522883-34-00 6 Metastatic cervical cancer
• Food effect and single- and multiple-ascending dose clinical trial of DF2755A in healthy participants Pending
  2025-522935-32-00 3 interstitial cystitis/bladder pain syndrome
• PODOMOUNT-Basket, a study to test whether BI 764198 helps adults and adolescents with different types of kidney disease Pending
  2025-523425-17-00 4 Proteinuric kidney diseases
• A Study of Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC Pending
  2025-523576-23-00 5 Unresectable Stage III non-small cell lung cancer without progression
• A Randomized, Double-Blind, Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treat … Pending
  2025-523735-19-00 5 Metastatic Microsatellite Stable Colorectal Cancer
• A study in people with advanced extrapulmonary neuroendocrine cancer to compare obrixtamig plus carboplatin and etoposide treatment with sta … Pending
  2025-523869-22-00 5 advanced or metastatic extrapulmonary neuroendocrine carcinoma
• Adjuvant Pembrolizumab in patients with early-stage triple negative breast cancer with residual disease after treatment with chemotherapy an … Pending
  2025-524229-41-00 5 Triple negative breast cancer
• GRAIN, Prospective Pilot Study Pending
  2025-524470-41-00 1 Esophageal adenocarcinoma
• A PHASE 1, OPEN-LABEL STUDY TO ASSESS THE ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION, INCLUDING THE MASS BALANCE, OF A SINGLE ORAL … Pending
  2025-524832-20-00 3 Healthy volunteers
• A study investigating the safety and efficacy of academically-produced CAR T cells compared with standard treatment for patients with multip … Pending
  2025-524876-43-00 5 relapsed/refractory multiple myeloma

Showing 25–48 of 679 trials